(TBI) TrueBlue - Ratings and Ratios
Staffing, Recruitment, Workforce, Management, Services
TBI EPS (Earnings per Share)
TBI Revenue
Description: TBI TrueBlue
TrueBlue Inc (NYSE:TBI) is a leading provider of specialized workforce solutions across North America and other regions, operating through three main segments: PeopleReady, PeopleManagement, and PeopleScout. PeopleReady offers contingent staffing services for various industries, including construction and manufacturing. PeopleManagement provides on-site industrial staffing and commercial driver services, while PeopleScout delivers recruitment process outsourcing and talent advisory services.
To analyze TrueBlues performance, we can look at key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow. Given the companys business model, its essential to monitor metrics like days sales outstanding (DSO) and revenue per employee. The companys ability to manage its workforce solutions and expand its client base will be crucial in driving revenue growth. We should also examine the companys competitive positioning within the human resource and employment services industry, including its market share and customer retention rates.
From a financial perspective, TrueBlues market capitalization is approximately $195.91 million, with a forward P/E ratio of 56.18, indicating a relatively high valuation. The negative return on equity (RoE) of -43.17 suggests that the company has faced challenges in generating profits. To better understand the companys financial health, we should analyze its debt-to-equity ratio, interest coverage, and other relevant metrics.
To make informed investment decisions, its crucial to assess TrueBlues growth prospects, competitive advantages, and potential risks. This includes evaluating the companys ability to adapt to changing market conditions, its investment in technology and innovation, and its strategies for expanding its services and client base. By examining these factors, we can gain a deeper understanding of TrueBlues fundamental value and potential for long-term growth.
TBI Stock Overview
| Market Cap in USD | 179m |
| Sub-Industry | Human Resource & Employment Services |
| IPO / Inception | 1996-06-13 |
TBI Stock Ratings
| Growth Rating | -76.0% |
| Fundamental | 17.9% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -32.8% |
| Analyst Rating | 4.0 of 5 |
TBI Dividends
Currently no dividends paidTBI Growth Ratios
| Growth Correlation 3m | -68.8% |
| Growth Correlation 12m | -61.4% |
| Growth Correlation 5y | -86% |
| CAGR 5y | -33.24% |
| CAGR/Max DD 3y | -0.40 |
| CAGR/Mean DD 3y | -0.71 |
| Sharpe Ratio 12m | 0.48 |
| Alpha | -40.43 |
| Beta | 0.980 |
| Volatility | 64.21% |
| Current Volume | 146.7k |
| Average Volume 20d | 116.3k |
| Stop Loss | 5.6 (-6.5%) |
| Signal | 0.94 |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-33.8m TTM) > 0 and > 6% of Revenue (6% = 92.1m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -6.61pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.04% (prev 8.08%; Δ 0.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.05 (>3.0%) and CFO -34.9m <= Net Income -33.8m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.9m) change vs 12m ago -1.62% (target <= -2.0% for YES) |
| Gross Margin 24.47% (prev 24.97%; Δ -0.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 219.8% (prev 243.8%; Δ -23.99pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -9.04 (EBITDA TTM -12.8m / Interest Expense TTM 3.74m) >= 6 (WARN >= 3) |
Altman Z'' 3.48
| (A) 0.21 = (Total Current Assets 286.9m - Total Current Liabilities 148.1m) / Total Assets 672.8m |
| (B) 0.49 = Retained Earnings (Balance) 326.8m / Total Assets 672.8m |
| (C) -0.05 = EBIT TTM -33.8m / Avg Total Assets 698.2m |
| (D) 0.83 = Book Value of Equity 305.2m / Total Liabilities 367.6m |
| Total Rating: 3.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 17.94
| 1. Piotroski 1.0pt = -4.0 |
| 2. FCF Yield -18.61% = -5.0 |
| 3. FCF Margin -2.68% = -1.01 |
| 4. Debt/Equity 0.21 = 2.48 |
| 5. Debt/Ebitda -5.08 = -2.50 |
| 6. ROIC - WACC -17.88% = -12.50 |
| 7. RoE -10.83% = -1.81 |
| 8. Rev. Trend -91.14% = -4.56 |
| 9. Rev. CAGR -12.70% = -2.12 |
| 10. EPS Trend -42.21% = -1.06 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of TBI shares?
Over the past week, the price has changed by +2.92%, over one month by +2.92%, over three months by -13.56% and over the past year by -20.56%.
Is TrueBlue a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TBI is around 4.03 USD . This means that TBI is currently overvalued and has a potential downside of -32.72%.
Is TBI a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.7 | 44.7% |
| Analysts Target Price | 8.7 | 44.7% |
| ValueRay Target Price | 4.5 | -25.4% |
Last update: 2025-09-01 05:03
TBI Fundamental Data Overview
CCE Cash And Equivalents = 21.9m USD (last quarter)
P/E Forward = 56.1798
P/S = 0.1163
P/B = 0.5849
P/EG = 4.0048
Beta = 1.557
Revenue TTM = 1.53b USD
EBIT TTM = -33.8m USD
EBITDA TTM = -12.8m USD
Long Term Debt = 53.8m USD (from longTermDebt, last quarter)
Short Term Debt = 11.0m USD (from shortTermDebt, last quarter)
Debt = 64.8m USD (Calculated: Short Term 11.0m + Long Term 53.8m)
Net Debt = 88.2m USD (from netDebt column, last quarter)
Enterprise Value = 221.4m USD (178.5m + Debt 64.8m - CCE 21.9m)
Interest Coverage Ratio = -9.04 (Ebit TTM -33.8m / Interest Expense TTM 3.74m)
FCF Yield = -18.61% (FCF TTM -41.2m / Enterprise Value 221.4m)
FCF Margin = -2.68% (FCF TTM -41.2m / Revenue TTM 1.53b)
Net Margin = -2.21% (Net Income TTM -33.8m / Revenue TTM 1.53b)
Gross Margin = 24.47% ((Revenue TTM 1.53b - Cost of Revenue TTM 1.16b) / Revenue TTM)
Tobins Q-Ratio = 0.73 (Enterprise Value 221.4m / Book Value Of Equity 305.2m)
Interest Expense / Debt = 4.48% (Interest Expense 2.90m / Debt 64.8m)
Taxrate = 21.0% (US default)
NOPAT = -33.8m (EBIT -33.8m, no tax applied on loss)
Current Ratio = 1.94 (Total Current Assets 286.9m / Total Current Liabilities 148.1m)
Debt / Equity = 0.21 (Debt 64.8m / last Quarter total Stockholder Equity 305.2m)
Debt / EBITDA = -5.08 (Net Debt 88.2m / EBITDA -12.8m)
Debt / FCF = -1.57 (Debt 64.8m / FCF TTM -41.2m)
Total Stockholder Equity = 312.5m (last 4 quarters mean)
RoA = -5.03% (Net Income -33.8m, Total Assets 672.8m )
RoE = -10.83% (Net Income TTM -33.8m / Total Stockholder Equity 312.5m)
RoCE = -9.22% (Ebit -33.8m / (Equity 312.5m + L.T.Debt 53.8m))
RoIC = -9.87% (NOPAT -33.8m / Invested Capital 342.3m)
WACC = 8.01% (E(178.5m)/V(243.3m) * Re(9.63%)) + (D(64.8m)/V(243.3m) * Rd(4.48%) * (1-Tc(0.21)))
Shares Correlation 3-Years: -69.70 | Cagr: -0.86%
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -41.2m)
Revenue Correlation: -91.14 | Revenue CAGR: -12.70%
Rev Growth-of-Growth: 5.94
EPS Correlation: -42.21 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 110.9
Additional Sources for TBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle